@misc{SchumannRoginSchneideretal.2012, author = {Schumann, C. and Rogin, S. and Schneider, H. and Oster, J. and Tippk{\"o}tter, Nils and Kampeis, P.}, title = {Steuerung von HGMS-Prozessen mittels Durchflusszytometrie}, series = {Chemie Ingenieur Technik}, volume = {84}, journal = {Chemie Ingenieur Technik}, number = {8}, publisher = {Wiley-VCH}, address = {Weinheim}, issn = {0009-286X}, doi = {10.1002/cite.201250125}, pages = {1370}, year = {2012}, abstract = {Die Hochgradientenmagnetseparation (HGMS) ist eine Methode zur Aufreinigung von biopharmazeutischen Produkten. Mit dieser Methode l{\"a}sst sich in nur einem Schritt eine Fest/Fest/Fl{\"u}ssig-Trennung erzielen, was zu einer erheblichen Zeit- und Kostenersparnis im Downstreaming f{\"u}hrt. Dennoch steht ihr industrieller Einsatz noch aus, was u. a. am Mangel an Analysenmethoden liegt, um die HGMS quantifizierbar zu machen. Gerade in der Pharmaproduktion werden Prozesse gebraucht, die gem{\"a}ß den einschl{\"a}gigen Vorschriften (cGMP) validiert und deren verfahrenstechnische Anlagenteile qualifiziert werden k{\"o}nnen. Die Schwierigkeit ist die Messung der magnetischen Mikrosorbentien in der Suspension, in der auch Zellen oder Zelltr{\"u}mmer vorliegen. Im Rahmen eines Forschungsprojektes im „Zentralen Innovationsprogramm Mittelstand" des BMWi wurden verschiedene Analysenmethoden untersucht. Die Durchflusszytometrie erm{\"o}glicht eine Charakterisierung von Partikeln und eine simultane quantitative Messung. Durch die multiparametrige Messung kann zwischen Zellen, Zelltr{\"u}mmern und Magnetpartikeln unterschieden werden. Die At-line-Einbindung des Durchflusszytometers ist durch den Einsatz einer externen Pumpe m{\"o}glich. {\"U}ber eine automatisierte Messwertanalyse kann der HGMS-Prozess mittels der Durchflusszytometrie gesteuert werden.}, language = {de} } @misc{LindelGreiserWaxmanetal.2012, author = {Lindel, Tomasz Dawid and Greiser, Andreas and Waxman, Patrick and Dietterle, Martin and Seifert, Frank and Fontius, Ulrich and Renz, Wolfgang and Dieringer, Matthias A. and Frauenrath, Tobias and Schulz-Menger, Jeanette and Niendorf, Thoralf and Ittermann, Bernd}, title = {Cardiac CINE MRI at 7 T using a transmit array}, series = {2012 ISMRM Annual Meeting Proceedings}, journal = {2012 ISMRM Annual Meeting Proceedings}, issn = {1545-4428}, year = {2012}, abstract = {With its need for high SNR and short acquisition times, Cardiac MRI (CMR) is an intriguing target application for ultrahigh field MRI. Due to the sheer size of the upper torso, however, the known RF issues of 7T MRI are also most prominent in CMR. Recent years brought substantial progress but the full potential of the ultrahigh field for CMR is yet to be exploited. Parallel transmission (pTx) is a promising approach in this context and several groups have already reported B1 shimming for 7T CMR. In such a static pTx application amplitudes and phases of all Tx channels are adjusted individually but otherwise imaging techniques established in current clinical practice 1.5 T and 3 T are applied. More advanced forms of pTx as spatially selective excitation (SSE) using Transmit SENSE promise additional benefits like faster imaging with reduced fields of view or improved SAR control. SSE requires the full dynamic capabilities of pTx, however, and for the majority of today's implemented pTx hardware the internal synchronization of the Tx array does not easily permit external triggering as needed for CMR. Here we report a software solution to this problem and demonstrate the feasibility of CINE CMR at 7 T using a Tx array.}, language = {en} } @incollection{Fabo2012, author = {Fabo, Sabine}, title = {Einf{\"u}hrung}, series = {Vielen Dank f{\"u}r Ihren Einkauf : Konsumkultur aus Sicht von Design, Kunst und Medien}, booktitle = {Vielen Dank f{\"u}r Ihren Einkauf : Konsumkultur aus Sicht von Design, Kunst und Medien}, publisher = {Transcript Verlag}, address = {Bielefeld}, isbn = {978-3-8376-2170-9}, pages = {9 -- 13}, year = {2012}, language = {de} } @article{FerreinMeyer2012, author = {Ferrein, Alexander and Meyer, Thomas}, title = {A Brief Overview of Artificial Intelligence in South Africa}, series = {AI Magazine}, volume = {33}, journal = {AI Magazine}, number = {1}, publisher = {AAAI}, address = {Menlo Park}, issn = {0738-4602}, doi = {10.1609/aimag.v33i1.2357}, pages = {99 -- 101}, year = {2012}, abstract = {South Africa in recent years is the establishment of a number of research hubs involved in AI activities ranging from mobile robotics and computational intelligence, to knowledge representation and reasoning, and human language technologies. In this survey we take the reader through a quick tour of the research being conducted at these hubs, and touch on an initiative to maintain and extend the current level of interest in AI research in the country.}, language = {en} } @article{BragardvanHoekDeDoncker2012, author = {Bragard, Michael and van Hoek, H. and De Doncker, R. W.}, title = {A major design step in IETO concept realization that allows overcurrent protection and pushes limits of switching performance}, series = {IEEE transactions on power electronics}, volume = {27}, journal = {IEEE transactions on power electronics}, number = {9}, publisher = {IEEE}, address = {New York}, issn = {0885-8993}, doi = {10.1109/TPEL.2012.2189136}, pages = {4163 -- 4171}, year = {2012}, abstract = {This paper presents the latest prototype of the integrated emitter turn-off thyristor concept, which potentially ranks among thyristor high-power devices like the gate turn-off thyristor and the integrated gate-commutated thyristor (IGCT). Due to modifications of the external driver stage and mechanical press-pack design optimization, this prototype allows for full device characterization. The turn-off capability was increased to 1600 A with an active silicon area of 823mm2 . This leads to a transient peak power of 672.1kW/cm² . Within this paper, measurements and concept assessment are presented and a comparison to state-of-the-art IGCT devices is provided.}, language = {en} } @misc{TippkoetterUlber2012, author = {Tippk{\"o}tter, Nils and Ulber, Roland}, title = {Rezension zu: Encyclopedia of Industrial Biotechnology, Vol. 1-7. By MC Flickinger.}, series = {Chemie Ingenieur Technik}, volume = {6}, journal = {Chemie Ingenieur Technik}, number = {84}, publisher = {Wiley-VCH}, address = {Weinheim}, issn = {0009-286X}, doi = {10.1002/cite.201290052}, pages = {936}, year = {2012}, language = {en} } @misc{TippkoetterStaubSohlingetal.2012, author = {Tippk{\"o}tter, Nils and Staub, C. and Sohling, U. and Ruf, N. and Ulber, Roland}, title = {Adsorptive Aufreinigung von Molkeproteinen}, series = {Chemie Ingenieur Technik}, volume = {84}, journal = {Chemie Ingenieur Technik}, number = {8}, publisher = {Wiley-VCH}, address = {Weinheim}, issn = {0009-286X}, doi = {10.1002/cite.201250395}, pages = {1285}, year = {2012}, abstract = {In der Molkeverarbeitung dominieren Membranfiltrationsverfahren die Prozessf{\"u}hrung. Hierbei werden {\"u}blicherweise Aufkonzentrierungen der Proteine und deren Trennung von dem Milchzucker Lactose durchgef{\"u}hrt. Der Prozess der adsorptiven Aufreinigung soll als kosteng{\"u}nstige Alternative zu den bisher gebr{\"a}uchlichen Verfahren dienen. Weiterhin er{\"o}ffnet sich durch das Verfahren die M{\"o}glichkeit, einzelne Proteinfraktionen w{\"a}hrend der Verarbeitung anzureichern. Als Proteinquellen wurden f{\"u}r die Untersuchungen Modellproteine, L{\"o}sungen aus Molkenproteinisolat, D{\"u}nnmolke und Molkekonzentrat verwendet. Die Eignung zur Proteinbindung wurden an Tonmaterialien, Silicaten und y-Aluminiumoxiden in Pulverform, in Form von Granulaten sowie Extrudaten als auch sph{\"a}rischen Partikeln {\"u}berpr{\"u}ft. Adsorbentien aus Bentonit/Silica und c-Aluminiumoxid k{\"o}nnen sowohl a-Lactalbumin (aLA) als auch b-Lactoglobulin (bLG) binden, wohingegen Materialien aus Siliciumoxid lediglich ein starkes Adsorptionsverhalten gegen{\"u}ber bLG zeigen. Mischmaterialien aus Siliciumoxid und a-Aluminiumoxid zeigen dasselbe Verhalten wie Materialien aus Siliciumoxid, weisen jedoch eine geringere Kapazit{\"a}t auf. Die Materialen wurden hinsichtlich ihres Einsatzes in chromatographischen Verfahren und Batch-Prozessen untersucht und ein Prozessentwurf f{\"u}r einen zweistufigen Batch-Prozess im R{\"u}hrkessel erarbeitet.}, language = {de} } @incollection{Fabo2012, author = {Fabo, Sabine}, title = {Gef{\"a}hrliche Liebschaften : Kunst zwischen Wderstand und Umarmung}, series = {Interventionen : Grenz{\"u}berschreitungen in {\"A}sthetik, Politik und {\"O}konomie}, booktitle = {Interventionen : Grenz{\"u}berschreitungen in {\"A}sthetik, Politik und {\"O}konomie}, editor = {Hartmann, Doreen and [u.a.],}, publisher = {Fink}, address = {M{\"u}nchen [u.a.]}, isbn = {978-3-7705-5283-2}, pages = {173 -- 189}, year = {2012}, language = {de} } @misc{TkachenkovonKnobelsdorffBrenkenhoffKleindienstetal.2012, author = {Tkachenko, Valeriy and von Knobelsdorff-Brenkenhoff, Florian and Kleindienst, Denise and Winter, Lukas and Rieger, Jan and Frauenrath, Tobias and Dieringer, Matthias A. and Santoro, Davide and Niendorf, Thoralf and Schulz-Menger, Jeanette}, title = {Cardiovasular MR at 7Tesla: assessment of the right ventricle}, series = {2012 ISMRM Annual Meeting Proceedings}, journal = {2012 ISMRM Annual Meeting Proceedings}, issn = {1545-4428}, year = {2012}, abstract = {The assessment of the right ventricle (RV) is a challenge in today's cardiology, but of growing clinical impact regarding patient prognosis in different cardiac diseases. The detection and differentiation of small wall motion abnormalities may help to enhance the differentiation of cardiomyopathies including Arrhythmogenic Rightventricular Cardiomyopathy. Cardiovascular magnetic resonance (CMR) at 1.5T is the accepted gold standard for RV quantification. The higher spatial resolution achievable at ultrahigh field strength (UHF) offers the potential to gain new insights into the structure and function of the RV. To approach this goal accurate RV chamber quantification at 7T has to be proven. Consequently this study examines the feasibility of assessment of RV dimensions and function at 7T using improved spatial resolution enabled by the intrinsic sensitivity gain of UHF CMR. For this purpose, a dedicated 16 channel TX/RX RF coil array is used together with 2D CINE fast gradient echo (FGRE) imaging. For comparison RV chamber quantification is conducted at 1.5T using a SSFP based state of the art clinical protocol.}, language = {en} } @article{ScheerBalimaneHaywardetal.2012, author = {Scheer, Nico and Balimane, Praveen and Hayward, Michael D. and Buechel, Sandra and Kauselmann, Gunther and Wolf, C. Roland}, title = {Generation and Characterization of a Novel Multidrug Resistance Protein 2 Humanized Mouse Line}, series = {Drug Metabolism and Disposition}, volume = {40}, journal = {Drug Metabolism and Disposition}, number = {11}, publisher = {ASPET}, address = {Bethesda, Md.}, issn = {1521-0111}, doi = {10.1124/dmd.112.047605}, pages = {2212 -- 2218}, year = {2012}, abstract = {The multidrug resistance protein (MRP) 2 is predominantly expressed in liver, intestine, and kidney, where it plays an important role in the excretion of a range of drugs and their metabolites or endogenous compounds into bile, feces, and urine. Mrp knockout [Mrp2(-/-)] mice have been used recently to study the role of MRP2 in drug disposition. Here, we describe the first generation and initial characterization of a mouse line humanized for MRP2 (huMRP2), which is nulled for the mouse Mrp2 gene and expresses the human transporter in the organs and cell types where MRP2 is normally expressed. Analysis of the mRNA expression for selected cytochrome P450 and transporter genes revealed no major changes in huMRP2 mice compared with wild-type controls. We show that human MRP2 is able to compensate functionally for the loss of the mouse transporter as demonstrated by comparable bilirubin levels in the humanized mice and wild-type controls, in contrast to the hyperbilirubinemia phenotype that is observed in MRP2(-/-) mice. The huMRP2 mouse provides a model to study the role of the human transporter in drug disposition and in assessing the in vivo consequences of inhibiting this transporter by compounds interacting with human MRP2.}, language = {en} }